Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows

Mar 30 2020

• By Bridget Silverman

Coronavirus

Related Content

Some Caution Over 'People’s Hope' Remdesivir As China Trials Progress

Mar 18 2020

As Chloroquine Demand Surges, Bayer Looks To Emergency Use Authorization To Enter US Market

Mar 23 2020

COVID-19 Study Of Gilead’s Remdesivir Using Ebola-Style Adaptive Platform Trial

Mar 17 2020

Related Companies

AbbVie Inc.

Roche Holding AG

Gilead Sciences, Inc.

Additional Topics

Coronavirus COVID-19 Clinical Trials Research & Development Infectious Diseases BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window